TY  - GEN
AU  - Tomblyn,Marcie R
AU  - Ewell,Marian
AU  - Bredeson,Christopher
AU  - Kahl,Brad S
AU  - Goodman,Stacey A
AU  - Horowitz,Mary M
AU  - Vose,Julie M
AU  - Negrin,Robert S
AU  - Laport,Ginna G
TI  - Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response
SN  - 1523-6536
PY  - 2011///1003
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Etoposide
KW  - Female
KW  - Graft vs Host Disease
KW  - prevention & control
KW  - Graft vs Tumor Effect
KW  - HLA Antigens
KW  - immunology
KW  - Hematopoietic Stem Cell Transplantation
KW  - methods
KW  - Histocompatibility
KW  - Humans
KW  - Living Donors
KW  - Lymphoma, Follicular
KW  - drug therapy
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Remission Induction
KW  - Rituximab
KW  - Salvage Therapy
KW  - Siblings
KW  - Tacrolimus
KW  - Transplantation Conditioning
KW  - adverse effects
KW  - Transplantation, Autologous
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - Whole-Body Irradiation
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.bbmt.2010.11.004
ER  -